Intas Pharmaceuticals Limited Sertraline Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Sertraline Export Records India — #13 Exporter, 414 Shipments, $2.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sertraline

India Pharmaceutical Trade Intelligence

$560.5M218 Suppliers88 CountriesHS 30049099

ExportsIndia → UNITED STATES60.3%India → BELGIUM10.4%

ImportsUNITED STATES → India$192.5K GERMANY → India$14.4K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Intas Pharmaceuticals Limited — Sertraline Exporter #13 | $2.3M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Sertraline Exporter Profile

Indian Pharmaceutical Exporter · #13 for Sertraline · $2.3M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #13 Indian exporter of Sertraline with $2.3M in export value and 414 verified shipments. Intas Pharmaceuticals Limited holds a 0.9% market share in Sertraline exports across 12 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Sertraline Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Sertraline export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Sertraline?

Country	Value	Shipments	Share
NETHERLANDS	$755.0K	85	36.6%
UNITED KINGDOM	$585.9K	37	28.4%
MEXICO	$201.7K	12	9.8%
POLAND	$170.7K	61	8.3%
BRAZIL

Who Are the Top Buyers of Sertraline from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
BROCACEF NL : HUB	NETHERLANDS	$378.9K	56
TO THE ORDER	MAURITIUS	$345.1K	15
ACCORD UK	UNITED KINGDOM	$309.7K	16
ACCORD FARMA S.A. DE C.V.	MEXICO	$201.7K	12
BROCACEF NL:EU HUB	NETHERLANDS	$132.6K	10
ACCORD FARMACUTICA LTDA.	BRAZIL	$132.5K	26
ACCORD HEALTHCARE PTE LTD	SINGAPORE	$79.9K	4
BROCACEF NL HUB BROCACEF HEALTHCAR	NETHERLANDS	$71.7K	5
BROCACEF NL:HUB	NETHERLANDS	$67.2K	6
BROCACEF NL HUB	NETHERLANDS	$53.6K	3

Intas Pharmaceuticals Limited supplies Sertraline to 33 buyers globally. The largest buyer is BROCACEF NL : HUB (NETHERLANDS), followed by TO THE ORDER (MAURITIUS) and ACCORD UK (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sertraline Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARM DRUG&MED:SERTRALIN 50MG 28000T TLB(ACO-EUROPE)EACH FILM COATED TABLET CONTSERTRALINE HYDROCHLORIDE PH.E(ASPERINV)	$190.4K	4
PHARMA DRUGS & MEDI SERTRALINE 100MG 250	$108.2K	7
PHARMA DRUGS AND MEDICINE-ACORTRAL-50MG14 TAB(E1)EACH FILM COATED TABLET CONTAINS:SERTRALINE-QTY-136447X1X14T-AS PER INTBS	$94.6K	3
PHARMA DRUGS & MEDI SERTRALINE 100MG 10X	$82.9K	4
PHARMA DRUGS AND MEDICINE-ACORTRAL-50MG14 TAB(E1)EACH FILM COATED TABLET CONTAINS:SERTRALINE QTY-99220X1X14T-AS PER INVTBS	$69.3K	3
PHARMA DRUGS & MEDI SERTRALINE 50MG 250T	$66.1K	9
PHARM DRUG&MED:SERTRALIN 100MG 14000T TLB(ACO-EUROPE)EACH FILM COATED TABLET CONT SERTRALINE HYDROCHLORIDE PH (ASPERINV)	$65.7K	2
PH.DRU.& MED.: ACOLOFT 50MG TABLETS (SERTRALINE 50MG TABLETS EACH TABLET CONT. SERTRALINE 50MG) [2X14T PER PACK] BATCH N	$63.0K	2
PHARMA DRUGS & MEDI SERTRALINE 50MG 3X10	$63.0K	6
PHARMA DRUGS & MEDI SERTRALINE 50MG 2X14	$62.6K	6

Intas Pharmaceuticals Limited exports 152 distinct Sertraline formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARM DRUG&MED:SERTRALIN 50MG 28000T TLB(ACO-EUROPE)EACH FIL with 4 shipments worth $190.4K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Sertraline Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	MEDREICH LIMITED	$2.4M	70	1	$34.5K
11	TORRENT PHARMACEUTICALS LIMITED	$2.4M	47	5	$50.0K
13	INTAS PHARMACEUTICALS LIMITED ★	$2.3M	414	12	$5.6K
14	ZYDUS LIFESCIENCES LIMITED	$2.0M	95	9	$20.9K
15	EMIL PHARMACEUTICAL INDUSTRIES PVT LTD	$1.8M	53	3	$34.6K

Intas Pharmaceuticals Limited ranks #13 among 218 Indian Sertraline exporters. Average shipment value of $5.6K compared to the market average of $691.9K. The closest competitors by value are MEDREICH LIMITED and TORRENT PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Sertraline Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	592	11.4%
SAHAR AIR	498	9.6%
NHAVA SHEVA SEA (INNSA1)	382	7.4%
DHANNAD ICD	268	5.2%
HYDERABAD ICD	184	3.6%
DHANNAD ICD (INDHA6)	177	3.4%
DELHI AIR	173	3.3%
VIZAG SEA (INVTZ1)	172	3.3%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Sertraline Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sertraline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 427 individual customs records matching Intas Pharmaceuticals Limited exporting Sertraline, covering 152 formulations to 13 countries via 33 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 88+ countries, 553+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sertraline

Sertraline

Intas Pharmaceuticals Limited — Sertraline Exporter Profile

Intas Pharmaceuticals Limited — Sertraline Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Sertraline?

Who Are the Top Buyers of Sertraline from Intas Pharmaceuticals Limited?

What Is India's Total Sertraline Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Sertraline Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Sertraline Exporters?

What Sertraline Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Sertraline to Key Markets

United Kingdom — MHRA

Mexico — COFEPRIS

How Does Intas Pharmaceuticals Limited Compare to Nearest Sertraline Exporters?

Which Indian Ports Ship Sertraline Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Sertraline Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sertraline Export Data from Intas Pharmaceuticals Limited

Sertraline Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source